全文获取类型
收费全文 | 62797篇 |
免费 | 7929篇 |
国内免费 | 1196篇 |
专业分类
耳鼻咽喉 | 530篇 |
儿科学 | 2377篇 |
妇产科学 | 2071篇 |
基础医学 | 4313篇 |
口腔科学 | 1385篇 |
临床医学 | 7489篇 |
内科学 | 12126篇 |
皮肤病学 | 602篇 |
神经病学 | 3807篇 |
特种医学 | 1277篇 |
外国民族医学 | 5篇 |
外科学 | 5599篇 |
综合类 | 5557篇 |
现状与发展 | 9篇 |
一般理论 | 9篇 |
预防医学 | 11586篇 |
眼科学 | 1102篇 |
药学 | 5145篇 |
40篇 | |
中国医学 | 749篇 |
肿瘤学 | 6144篇 |
出版年
2024年 | 146篇 |
2023年 | 1564篇 |
2022年 | 1855篇 |
2021年 | 3947篇 |
2020年 | 3546篇 |
2019年 | 3301篇 |
2018年 | 3200篇 |
2017年 | 3053篇 |
2016年 | 3134篇 |
2015年 | 2891篇 |
2014年 | 4715篇 |
2013年 | 6137篇 |
2012年 | 3583篇 |
2011年 | 3818篇 |
2010年 | 2927篇 |
2009年 | 2833篇 |
2008年 | 2907篇 |
2007年 | 2623篇 |
2006年 | 2334篇 |
2005年 | 2012篇 |
2004年 | 1664篇 |
2003年 | 1458篇 |
2002年 | 1186篇 |
2001年 | 1062篇 |
2000年 | 801篇 |
1999年 | 706篇 |
1998年 | 620篇 |
1997年 | 534篇 |
1996年 | 411篇 |
1995年 | 416篇 |
1994年 | 347篇 |
1993年 | 333篇 |
1992年 | 286篇 |
1991年 | 228篇 |
1990年 | 208篇 |
1989年 | 167篇 |
1988年 | 155篇 |
1987年 | 127篇 |
1986年 | 102篇 |
1985年 | 132篇 |
1984年 | 99篇 |
1983年 | 64篇 |
1982年 | 82篇 |
1981年 | 59篇 |
1980年 | 44篇 |
1979年 | 26篇 |
1978年 | 18篇 |
1977年 | 18篇 |
1976年 | 14篇 |
1973年 | 9篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
51.
52.
53.
目的探讨新诊断2型糖尿病(T2DM)常见中医证型与非酒精性脂肪肝(NAFLD)及其相关危险因素的相关性,为中西医结合治疗提供临床指导。方法选择沧州中西医结合医院门诊和病房收治的300例新诊断T2DM患者作为研究对象,根据其是否合并NAFLD分为合并NAFLD组,单纯T2DM组。记录2组一般资料,依照《糖尿病中医防治指南》对所有患者进行辨证分型,记录2组腰围、身高、体质量、体质量指数(BMI)、肝功指标[丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)、γ-谷氨酰转肽酶(GGT)、碱性磷酸酶(ALP)]、血脂指标(TG、TC、HDL-C、LDL-C)及血尿酸(SUA)、空腹血糖(FPG)、空腹胰岛素(FINS)、空腹C-肽(FC-P)、胰岛素抵抗指数(HOMA-IR),分析各中医证型与客观化指标的关系。结果合并NAFLD组124例,单纯T2DM组176例,2组性别、年龄比较差异无统计学意义(P均>0.05);合并NAFLD组的痰湿郁阻证占比明显高于T2DM组(P<0.05),其余分型占比组间比较差异无统计学意义(P均>0.05);合并NAFLD组的腰围、BMI、TG、TC、FC-P、HOMA-IR均显著高于T2DM组(P均<0.05),其余指标2组比较差异无统计学意义(P均>0.05);非条件Logistic回归分析显示,NAFLD的独立危险因素为BMI、TG、HOMA-IR。结论痰湿郁阻证是T2DM合并NAFLD患者的最常见证型,肥胖、胰岛素抵抗、脂质代谢紊乱是T2DM合并NAFLD患者的独立危险因素。 相似文献
54.
Nicola Flaum Emma J. Crosbie Richard J. Edmondson Miriam J. Smith Dafydd G. Evans 《Clinical genetics》2020,97(1):54-63
Ovarian cancer is the fourth most common cause of cancer-related death in women in the developed world, and one of the most heritable cancers. One of the most significant risk factors for epithelial ovarian cancer (EOC) is a family history of breast and/or ovarian cancer. Combined risk factors can be used in models to stratify risk of EOC, and aid in decisions regarding risk-reduction strategies. Germline pathogenic variants in EOC susceptibility genes including those involved in homologous recombination and mismatch repair pathways are present in approximately 22% to 25% of EOC. These genes are associated with an estimated lifetime risk of EOC of 13% to 60% for BRCA1 variants and 10% to 25% for BRCA2 variants, with lower risks associated with remaining genes. Genome-wide association studies have identified single nucleotide polymorphisms (SNPs) thought to explain an additional 6.4% of the familial risk of ovarian cancer, with 34 susceptibility loci identified to date. However, an unknown proportion of the genetic component of EOC risk remains unexplained. This review comprises an overview of individual genes and SNPs suspected to contribute to risk of EOC, and discusses use of a polygenic risk score to predict individual cancer risk more accurately. 相似文献
55.
Kun Ma Jiayun Liu Youjin Wang Yubin Zhong Zhenfeng Wu Ruiying Fan Shanfeng Guo 《Journal of gastrointestinal oncology.》2020,11(6):1350
BackgroundOur study aims to investigate changes in cell-free DNA (cfDNA) concentration and integrity in primary hepatocellular carcinoma (PHC) patients before and after transcatheter arterial chemoembolization (TACE) treatment and their influence on the evaluation of prognosis of the disease.MethodsA total of 84 PHC patients admitted to the Affiliated Hospital of Nanjing University of Chinese Medicine from December 2016 to December 2017 were included as the study group, while 55 healthy people served as the control group. Plasma cfDNA concentration and integrity were determined using qRT-PCR. The correlation between cfDNA concentration/integrity and clinical characteristics of PHC patients were analyzed. A ROC curve was used to investigate the sensitivity and specificity of cfDNA as detection indices. Univariate and multivariate analyses were used to analyze factors affecting recurrence in PHC patients and compare recurrence-free survival (RFS) of PHC patients with high cfDNA expression and low cfDNA expression.ResultsPlasma cfDNA concentration and integrity were significantly higher in PHC patients before TACE treatment than in healthy people and significantly lower after treatment than before (P<0.05). The cfDNA concentration was significantly correlated with tumor size, lymph node metastasis, TNM stage, and BCLC stage, while cfDNA integrity was significantly correlated with tumor size, TNM stage, and BCLC stage (P<0.05). ROC results showed that the area under the curve (AUC) value of cfDNA concentration was the largest, with an optimal cut-off of 10.51 ng/mL. Multivariate regression analysis for COX showed that the TNM stage, cfDNA concentration, and AFP were independent risk factors that affected PHC patients’ survival.ConclusionsPlasma cfDNA concentration in PHC patients is more sensitive and specific than any other tumor marker. It is an independent risk factor for PHC patients treated with TACE. Therefore, it is hypothesized cfDNA is a potential biomarker for prognostic evaluation of PHC patients treated with TACE. 相似文献
56.
ObjectivesTo determine screening outcomes in women who have no recorded risk factors for breast cancer.MethodsA retrospective population-based cohort study included all 1,026,137 mammography screening episodes in 323,082 women attending the BreastScreen Western Australia (part of national biennial screening) program between July 2007 and June 2017. Cancer detection rates (CDR) and interval cancer rates (ICR) were calculated in screening episodes with no recorded risk factors for breast cancer versus at least one risk factor stratified by age. CDR was further stratified by timeliness of screening (<27 versus ≥27 months); ICR was stratified by breast density.ResultsAmongst 566,948 screens (55.3%) that had no recorded risk factors, 2347 (40.9%) screen-detected cancers were observed. In screens with no risk factors, CDR was 50 (95%CI 48–52) per 10,000 screens and ICR was 7.9 (95%CI 7.4–8.4) per 10,000 women-years, estimates that were lower than screens with at least one risk factor (CDR 83 (95%CI 80–86) per 10,000 screens, ICR 12.2 (95%CI 11.5–13.0) per 10,000 women-years). Compared to timely screens with risk factors, delayed screens with no risk factors had similar CDR across all age groups and a higher proportion of node positive cancers (26.1% vs 20.7%). ICR was lowest in screens that had no risk factors nor dense breasts in all age groups.ConclusionsMajority of screens had no recorded breast cancer risk factors, hence a substantial proportion of screen-detected cancers occur in these screening episodes. Our findings may not justify less frequent screening in women with no risk factors. 相似文献
57.
Parallel enzyme‐linked immunosorbent assay screening for human immunodeficiency virus among blood donors in five Chinese blood centres: a retrospective analysis 下载免费PDF全文
58.
59.
Evaluation of training nurses to perform semi‐automated three‐dimensional left ventricular ejection fraction using a customised workstation‐based training protocol 下载免费PDF全文
60.
彭梅琼 《中国继续医学教育》2020,(7):179-181
目的了解护理专案改善在降低住院患者跌倒发生率中的应用效果。方法将医院2016年1月—2018年12月的80例住院患者随机分组,传统护理组对于住院患者给予传统护理,护理专案模式组对于住院患者采取护理专案模式。比较两组满意评分;护理人员工作积极性评分;护理前后住院患者对跌倒危险因素的掌握水平、住院患者遵医行为;跌倒的发生率。结果护理专案模式组满意评分、住院患者对跌倒危险因素的掌握水平、住院患者遵医行为、护理人员工作积极性评分、跌倒的发生率对比传统护理组有优势,P<0.05。结论住院患者实施护理专案模式效果确切,可提高护理服务质量和住院患者自我防护能力,降低跌倒的发生率。 相似文献